| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1532-5415.2005.53504.X |
| P698 | PubMed publication ID | 16181168 |
| P50 | author | John A. Nyman | Q52646565 |
| Kristine Ensrud | Q84115152 | ||
| Robert L. Kane | Q112426389 | ||
| L. Joseph Melton | Q112619624 | ||
| P2093 | author name string | John T Schousboe | |
| P2860 | cites work | Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures | Q36598613 |
| Fracture risk in patients with Alzheimer's disease | Q40761329 | ||
| Forearm fractures as predictors of subsequent osteoporotic fractures | Q40783449 | ||
| Injurious falls in nonambulatory nursing home residents: a comparative study of circumstances, incidence, and risk factors | Q43538928 | ||
| Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. | Q53662122 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 1697-1704 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women | |
| P478 | volume | 53 |
| Q38155095 | A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures |
| Q34305113 | Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies |
| Q51165802 | Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis. |
| Q45424160 | Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis |
| Q46115086 | Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women |
| Q37312639 | Cost-effective osteoporosis treatment thresholds: the United States perspective |
| Q36793246 | Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures |
| Q37085615 | Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight. |
| Q35868662 | Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women |
| Q44886342 | Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy |
| Q88723376 | Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong |
| Q37199923 | Diagnosis and management of osteoporosis in the older senior |
| Q37707358 | Does the funding source influence the results in economic evaluations? A case study in bisphosphonates for the treatment of osteoporosis |
| Q34219193 | Efficacy of Dual Energy X-ray Absorptiometry for Evaluation of Biomechanical Properties: Bone Mineral Density and Actual Bone Strength |
| Q46356238 | Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures |
| Q35036417 | Gender differences in osteoporosis and fractures |
| Q28731336 | Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment |
| Q42646024 | Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. |
| Q38048913 | Inclusion of compliance and persistence in economic models: past, present and future |
| Q37738187 | Is osteoporosis disease management cost effective? |
| Q42565577 | Osteoporosis screening: mixed messages in primary care |
| Q45298789 | Percent body fat, fractures and risk of osteoporosis in women |
| Q80387623 | Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland |
| Q49808666 | The burden of hip fractures - why aren't we better at prevention? |
| Q36981426 | The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature |
| Q37188080 | The diagnosis and treatment of primary osteoporosis according to current guidelines |
| Q36543142 | Treating osteoporosis: economic aspects of bisphosphonate therapy |
| Q42949454 | Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention |
| Q41866663 | Treatment of Osteoporosis in Australian Residential Aged Care Facilities: Update on Consensus Recommendations for Fracture Prevention |
| Q82904029 | Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation: changes over the last decade |
| Q36258388 | Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study. |
| Q35830541 | Use of a clinical decision support system to increase osteoporosis screening |
| Q79235994 | Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model |
| Q84415921 | [Osteoporotic treatment options in geriatric patients] |
Search more.